ABOUT THIS STUDY
- Eligible patients were men and women with a minimum age limit of 18 years of age (in Canada there was also an age limit of 65 years) who were expected to have at least one attack of migraine with or without aura, as defined by the International Headache Society (IHS) criteria,15 every 6 weeks.
- Patients had to be capable of taking study medication as outpatients and recording the effects.
- Pregnant or breast-feeding women and those not using adequate contraception were
excluded from the trial.
- Patients with frequent nonmigrainous headache, atypical migraine that had not
previously responded to therapy, migraine with prolonged aura, familial hemiplegic
migraine, basilar migraine, or migrainous infarction were excluded from the trial.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Arhus C,
- Nykoebing F,
- Odense C,